Curaleaf Urges Aurora Cannabis Shareholders to Accept Takeover Offer
Curaleaf has sent a letter directly to Aurora Cannabis shareholders, urging them to accept its takeover offer after the board of Aurora rejected engagement with the proposal. The offer values each Aurora share at $4.00 based on an unaffected date, representing a 45% premium over Aurora's 30-day volume-weighted average price as of August 10, 2026. Shareholders would receive 0.3463 Curaleaf shares and $0.75 in cash for each Aurora share. Curaleaf highlighted potential annual cost synergies of at least $40 million from the transaction, with combined revenue expected to exceed $1.5 billion based on fiscal year-end data as of June 30, 2026. The company also pointed out Aurora's recent financial struggles, including a decline in net revenue and negative operating cash flow. Aurora shareholders have until December 1, 2026, to tender their shares under the offer.
Topics: Acquisition Cannabis Shareholder Tender